{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:20:36Z","timestamp":1791300036102,"version":"4.1.0"},"reference-count":187,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2008,8,11]],"date-time":"2008-08-11T00:00:00Z","timestamp":1218412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:p>Despite high\u2010dose intravenous immunoglobulin (IVIG) is widely used in treatment of a number of immune\u2010mediated neurological diseases, the consensus on its optimal use is insufficient. To define the evidence\u2010based optimal use of IVIG in neurology, the recent papers of high relevance were reviewed and consensus recommendations are given according to EFNS guidance regulations. The efficacy of IVIG has been proven in Guillain\u2010Barr\u00e9 syndrome (level A), chronic inflammatory demyelinating polyradiculoneuropathy (level A), multifocal mononeuropathy (level A), acute exacerbations of myasthenia gravis (MG) and short\u2010term treatment of severe MG (level A recommendation), and some paraneoplastic neuropathies (level B). IVIG is recommended as a second\u2010line treatment in combination with prednisone in dermatomyositis (level B) and treatment option in polymyositis (level C). IVIG should be considered as a second or third\u2010line therapy in relapsing\u2013remitting multiple sclerosis, if conventional immunomodulatory therapies are not tolerated (level B), and in relapses during pregnancy or post\u2010partum period (good clinical practice point). IVIG seems to have a favourable effect also in paraneoplastic neurological diseases (level A), stiff\u2010person syndrome (level A), some acute\u2010demyelinating diseases and childhood refractory epilepsy (good practice point).<\/jats:p>","DOI":"10.1111\/j.1468-1331.2008.02246.x","type":"journal-article","created":{"date-parts":[[2008,8,11]],"date-time":"2008-08-11T14:13:31Z","timestamp":1218464011000},"page":"893-908","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":243,"title":["EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases"],"prefix":"10.1111","volume":"15","author":[{"given":"I.","family":"Elovaara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Apostolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. E.","family":"Gilhus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hietaharju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Honkaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. N.","family":"Van Schaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Scolding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soelberg S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Udd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,8,11]]},"reference":[{"key":"e_1_2_18_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00867.x"},{"key":"e_1_2_18_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra993360"},{"key":"e_1_2_18_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1993.1057"},{"key":"e_1_2_18_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G"},{"key":"e_1_2_18_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2003.11.002"},{"key":"e_1_2_18_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-5728(95)00175-1"},{"key":"e_1_2_18_8_2","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.4049\/jimmunol.154.5.2460","article-title":"A monoclonal autoantibody that promotes central nervous system remyelination in a model of multiple sclerosis is a natural autoantibody encoded by germline immunoglobulin genes","volume":"154","author":"Miller DJ","year":"1995","journal-title":"Journal of Immunology"},{"key":"e_1_2_18_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00241-6"},{"key":"e_1_2_18_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(99)00035-1"},{"key":"e_1_2_18_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00243-0"},{"key":"e_1_2_18_12_2","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.161.7.3781","article-title":"Therapeutic preparations of normal polyspecific IgG (IVIG) induce apoptosis in human lymphocytes and monocytes: a novel mechanism of action of IVIG involving the Fas apoptotic pathway","volume":"161","author":"Prasad NK","year":"1998","journal-title":"Journal of Immunology"},{"key":"e_1_2_18_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(96)00053-6"},{"key":"e_1_2_18_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10205"},{"key":"e_1_2_18_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117520"},{"key":"e_1_2_18_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.51.5.605"},{"key":"e_1_2_18_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(78)91837-8"},{"key":"e_1_2_18_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.35.8.1096"},{"key":"e_1_2_18_19_2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.1986.03380100107031","article-title":"The utility of therapeutic plasmapheresis for neurological disorders. NIH Consensus Development","volume":"256","author":"Consensus Conference","year":"1986","journal-title":"The Journal of the American Medical Association"},{"key":"e_1_2_18_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.38.10.1639"},{"key":"e_1_2_18_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199204233261705"},{"key":"e_1_2_18_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.100"},{"key":"e_1_2_18_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09095-2"},{"key":"e_1_2_18_24_2","first-page":"69","article-title":"A randomized controlled trial comparing intravenous immunoglobulin and plasmapheresis in Guillain\u2010Barr\u00e9 syndrome","volume":"18","author":"Nomura K","year":"2001","journal-title":"Neurological Therapeutics"},{"key":"e_1_2_18_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000050777"},{"key":"e_1_2_18_26_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.71.2.235"},{"key":"e_1_2_18_27_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549509019016"},{"key":"e_1_2_18_28_2","first-page":"223","article-title":"Intravenous immunoglobulin in children with Guillain\u2010Barr\u00e9 syndrome","volume":"16","author":"Wang R","year":"2001","journal-title":"Journal of Applied Clinical Pediatrics"},{"key":"e_1_2_18_29_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-1324"},{"key":"e_1_2_18_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3798(97)80004-9"},{"key":"e_1_2_18_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15324-X"},{"key":"e_1_2_18_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)15367-6"},{"key":"e_1_2_18_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67665-9"},{"key":"e_1_2_18_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400209"},{"key":"e_1_2_18_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C"},{"key":"e_1_2_18_36_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.70.4.560"},{"key":"e_1_2_18_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000167549.09664.b8"},{"key":"e_1_2_18_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm004"},{"key":"e_1_2_18_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360607"},{"key":"e_1_2_18_40_2","article-title":"Intravenous immunoglobuline for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"2","author":"Van Schaik IN","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_18_41_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1067"},{"key":"e_1_2_18_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.1088"},{"key":"e_1_2_18_43_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.445"},{"key":"e_1_2_18_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00868527"},{"key":"e_1_2_18_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.56.1.36"},{"key":"e_1_2_18_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70329-0"},{"key":"e_1_2_18_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01278.x"},{"key":"e_1_2_18_48_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.7.778"},{"key":"e_1_2_18_49_2","first-page":"89","article-title":"Longterm iv immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy","volume":"12","author":"Van Doorn PA","year":"2007","journal-title":"Journal of the Peripheral Nervous System"},{"key":"e_1_2_18_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-5728(01)00266-1"},{"key":"e_1_2_18_51_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1480"},{"key":"e_1_2_18_52_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.533"},{"key":"e_1_2_18_53_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.4.1135"},{"key":"e_1_2_18_54_2","first-page":"CD004429","article-title":"Intravenous immunoglobuline for multifocal motor neuropathy","volume":"2","author":"Van Schaik IN","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_18_55_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.3_Part_1.429"},{"key":"e_1_2_18_56_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1256"},{"key":"e_1_2_18_57_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.1.145"},{"key":"e_1_2_18_58_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.3.248"},{"key":"e_1_2_18_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J"},{"key":"e_1_2_18_60_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2007.121756"},{"key":"e_1_2_18_61_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000110185.23464.A1"},{"key":"e_1_2_18_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.3.421"},{"key":"e_1_2_18_63_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000140497.85952.FA"},{"key":"e_1_2_18_64_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01466.x"},{"key":"e_1_2_18_65_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.11.1480"},{"key":"e_1_2_18_66_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410370705"},{"key":"e_1_2_18_67_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410360313"},{"key":"e_1_2_18_68_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410400516"},{"key":"e_1_2_18_69_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-002-0808-z"},{"key":"e_1_2_18_70_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.63.1.28"},{"key":"e_1_2_18_71_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002827.pub2"},{"key":"e_1_2_18_72_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.2.212"},{"key":"e_1_2_18_73_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.Suppl.46"},{"key":"e_1_2_18_74_2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00878529","article-title":"Neuropathy associated with \u201cbenign\u201d anti\u2010myelin\u2010associated glycoprotein IgM gammopathy: clinical, immunological, neurophysiological pathological findings and response to treatment in 33 cases","volume":"243","author":"Ellie E","year":"1996","journal-title":"Journal of Neurology"},{"key":"e_1_2_18_75_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.2.321"},{"key":"e_1_2_18_76_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.4.710"},{"key":"e_1_2_18_77_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1069"},{"key":"e_1_2_18_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/9780470753279.ch25"},{"key":"e_1_2_18_79_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.5.766"},{"key":"e_1_2_18_80_2","first-page":"979","article-title":"Neuropathies associated with IgG and IgA monoclonal gammopathy","volume":"158","author":"Nobile\u2010Orazio E","year":"2002","journal-title":"Revista de Neurologia (Paris)"},{"key":"e_1_2_18_81_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005376.pub2"},{"key":"e_1_2_18_82_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.47.3.678"},{"key":"e_1_2_18_83_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003279.pub2"},{"key":"e_1_2_18_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(00)00093-7"},{"key":"e_1_2_18_85_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.57.7.840"},{"key":"e_1_2_18_86_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.1.86"},{"key":"e_1_2_18_87_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.437"},{"key":"e_1_2_18_88_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.4.479"},{"key":"e_1_2_18_89_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_2_18_90_2","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis\u2014Efficacy and safety","volume":"27","author":"Al\u2010Mayouf SM","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_18_91_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.72.1.25"},{"key":"e_1_2_18_92_2","first-page":"111","article-title":"Intravenous immunoglobulin therapy in juvenile dermatomyositis","volume":"38","author":"Tsai MJ","year":"1997","journal-title":"Zhonghua Min Guo Xiao Erke Yi Xue Hui Za Zhi"},{"key":"e_1_2_18_93_2","first-page":"1092","article-title":"Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients","volume":"21","author":"Cherin P","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"e_1_2_18_94_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.61.1.37"},{"key":"e_1_2_18_95_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"e_1_2_18_96_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050005"},{"key":"e_1_2_18_97_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.3.323"},{"key":"e_1_2_18_98_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10053"},{"key":"e_1_2_18_99_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01476.x"},{"key":"e_1_2_18_100_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410410615"},{"key":"e_1_2_18_101_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.11.1689"},{"key":"e_1_2_18_102_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000256698.69121.45"},{"key":"e_1_2_18_103_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2001.06717.x"},{"key":"e_1_2_18_104_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10224"},{"key":"e_1_2_18_105_2","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/archinte.1986.00360190143020","article-title":"High\u2010dose intravenous immunoglobulin in the management of myasthenia\u2010gravis","volume":"146","author":"Arsura EL","year":"1986","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_18_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1991.tb04912.x"},{"key":"e_1_2_18_107_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02335664"},{"key":"e_1_2_18_108_2","first-page":"413","article-title":"A comparative study of intravenous immunoglobulin and plasmapheresis preoperatively in myasthenia","volume":"33","author":"Perez\u2010Nellar J","year":"2001","journal-title":"Revista de Neurologia"},{"key":"e_1_2_18_109_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.3.629"},{"key":"e_1_2_18_110_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.2006.00268.x"},{"key":"e_1_2_18_111_2","article-title":"Seronegative myasthenia with antibodies against muscle\u2010specific tyrosine kinase","volume":"75","author":"Hain B","year":"2004","journal-title":"Nervenarzt"},{"key":"e_1_2_18_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.05.065"},{"key":"e_1_2_18_113_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002277.pub2"},{"key":"e_1_2_18_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.01.002"},{"key":"e_1_2_18_115_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<551::AID-MUS14>3.0.CO;2-O"},{"key":"e_1_2_18_116_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200105000-00010"},{"key":"e_1_2_18_117_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-8467(02)00017-3"},{"key":"e_1_2_18_118_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01385.x"},{"key":"e_1_2_18_119_2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3928\/0147-7447-19911101-09","article-title":"Assessment and differential diagnosis for post\u2010polio syndrome","volume":"14","author":"Halstead LS","year":"1991","journal-title":"Orthopedics"},{"key":"e_1_2_18_120_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2004.01.010"},{"key":"e_1_2_18_121_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01552.x"},{"key":"e_1_2_18_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70447-1"},{"key":"e_1_2_18_123_2","doi-asserted-by":"publisher","DOI":"10.1080\/16501970500441625"},{"key":"e_1_2_18_124_2","first-page":"2357","article-title":"[Intravenous immunoglobulin in postpolio syndrome]","volume":"124","author":"Farbu E","year":"2004","journal-title":"Tidsskrift for den Norske Laegeforening"},{"key":"e_1_2_18_125_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.2.398"},{"key":"e_1_2_18_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09377-4"},{"key":"e_1_2_18_127_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00500.x"},{"key":"e_1_2_18_128_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.5.1273"},{"key":"e_1_2_18_129_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00501.x"},{"key":"e_1_2_18_130_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0537-6"},{"key":"e_1_2_18_131_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2006.12.018"},{"key":"e_1_2_18_132_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.10.1515"},{"key":"e_1_2_18_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17101-8"},{"key":"e_1_2_18_134_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458507078400"},{"key":"e_1_2_18_135_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00878527"},{"key":"e_1_2_18_136_2","doi-asserted-by":"publisher","DOI":"10.1177\/135245850000602S05"},{"key":"e_1_2_18_137_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458506075654"},{"key":"e_1_2_18_138_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000145798.61383.39"},{"key":"e_1_2_18_139_2","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms978sr"},{"key":"e_1_2_18_140_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.8.1135"},{"key":"e_1_2_18_141_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.11.1514"},{"key":"e_1_2_18_142_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.68.1.89"},{"key":"e_1_2_18_143_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0317167100053932"},{"key":"e_1_2_18_144_2","doi-asserted-by":"publisher","DOI":"10.1191\/135245855058ms1158oa"},{"key":"e_1_2_18_145_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(99)00042-9"},{"key":"e_1_2_18_146_2","first-page":"256","article-title":"Immunoglobulins in acute parainfectious disseminated encephalomyelitis","volume":"21","author":"Finsterer J","year":"1998","journal-title":"Clinical Pharmacology"},{"key":"e_1_2_18_147_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307380001500614"},{"key":"e_1_2_18_148_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200x.2004.01872.x"},{"key":"e_1_2_18_149_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.1204"},{"key":"e_1_2_18_150_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.6.1370"},{"key":"e_1_2_18_151_2","doi-asserted-by":"publisher","DOI":"10.1177\/088307389501000612"},{"key":"e_1_2_18_152_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.4.1173"},{"key":"e_1_2_18_153_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2001.tb00733.x"},{"key":"e_1_2_18_154_2","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007836"},{"key":"e_1_2_18_155_2","first-page":"327","article-title":"Acute disseminated encephalomyelitis following leptospirosis","volume":"52","author":"Chandra SR","year":"2004","journal-title":"The Journal of the Association of Physicians of India"},{"key":"e_1_2_18_156_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000179302.93960.ad"},{"key":"e_1_2_18_157_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(00)00229-0"},{"key":"e_1_2_18_158_2","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290006350"},{"key":"e_1_2_18_159_2","first-page":"e1","article-title":"Acute disseminated encephalomyelitis in children","volume":"110","author":"Krishna Murthy SN","year":"2002","journal-title":"Pediatrics"},{"key":"e_1_2_18_160_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.42.191"},{"key":"e_1_2_18_161_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2003.09.004"},{"key":"e_1_2_18_162_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0420.2006.00773.x"},{"key":"e_1_2_18_163_2","doi-asserted-by":"publisher","DOI":"10.1002\/jca.20103"},{"key":"e_1_2_18_164_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2004-2038"},{"key":"e_1_2_18_165_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa01167"},{"key":"e_1_2_18_166_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmrv.2007.01.002"},{"key":"e_1_2_18_167_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.10043"},{"key":"e_1_2_18_168_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.44.9.1652"},{"key":"e_1_2_18_169_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370621"},{"key":"e_1_2_18_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-3787(06)75086-X"},{"key":"e_1_2_18_171_2","first-page":"712","article-title":"Stiff\u2010man syndrome. Report of 4 cases","volume":"65","author":"Vieregge P","year":"1994","journal-title":"Nervenarzt"},{"key":"e_1_2_18_172_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K037"},{"key":"e_1_2_18_173_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncpneuro0376"},{"key":"e_1_2_18_174_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2005.00581.x"},{"key":"e_1_2_18_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2004.04.002"},{"key":"e_1_2_18_176_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.19.2367"},{"key":"e_1_2_18_177_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100720200013"},{"key":"e_1_2_18_178_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2007.01134.x"},{"key":"e_1_2_18_179_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-003-0087-1"},{"key":"e_1_2_18_180_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.2000.tb00257.x"},{"key":"e_1_2_18_181_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(01)00402-7"},{"key":"e_1_2_18_182_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-8994(97)00157-4"},{"key":"e_1_2_18_183_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1997.tb01740.x"},{"key":"e_1_2_18_184_2","doi-asserted-by":"publisher","DOI":"10.1177\/08830738020170101808"},{"key":"e_1_2_18_185_2","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200507060-00006"},{"key":"e_1_2_18_186_2","doi-asserted-by":"publisher","DOI":"10.1007\/s003810050423"},{"key":"e_1_2_18_187_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.2.248"},{"key":"e_1_2_18_188_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1085-1"}],"updated-by":[{"DOI":"10.1111\/j.1468-1331.2009.02594.x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000}}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2008.02246.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2008.02246.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:40:26Z","timestamp":1696898426000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2008.02246.x"}},"subtitle":["EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases"],"short-title":[],"issued":{"date-parts":[[2008,8,11]]},"references-count":187,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1111\/j.1468-1331.2008.02246.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2008.02246.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,11]]},"assertion":[{"value":"2008-08-11","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}